The Efficacy of Intravenous Amino Acids in Reducing the Occurrence of AKI After Live Donor Liver Transplant

NANot yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 25, 2025

Primary Completion Date

September 1, 2026

Study Completion Date

September 1, 2026

Conditions
Liver Transplant; ComplicationsAKI - Acute Kidney Injury
Interventions
DRUG

L-Amino acid mixture

Continuous infusion of a L-amino acids mixture in a dose of 2 g/kg dry body weight/day (to a maximum 100 g/day) after induction of anesthesia and insertion of CVP line till 72 hours after treatment initiation

OTHER

Standard of care

Standard peri tranplant care as per out institution including intra operative and post operative care. Its includes starting of immunosuppression after serial blood investigation monitoring.

Trial Locations (1)

110070

Ilbs Hospital, D1 Vasant Kunj, New Delhi, New Delhi

All Listed Sponsors
lead

Institute of Liver and Biliary Sciences, India

OTHER

NCT07132697 - The Efficacy of Intravenous Amino Acids in Reducing the Occurrence of AKI After Live Donor Liver Transplant | Biotech Hunter | Biotech Hunter